# Utility of Prolonged-release Pirfenidone in the Progression of Chronic Kidney Disease

> **NCT02408744** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Guadalajara** · enrollment: 30 (actual)

## Conditions studied

- Fibrosis
- Chronic Kidney Disease

## Interventions

- **DRUG:** Pirfenidone

## Key facts

- **NCT ID:** NCT02408744
- **Lead sponsor:** University of Guadalajara
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-09
- **Final completion:** 2013-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02408744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02408744, "Utility of Prolonged-release Pirfenidone in the Progression of Chronic Kidney Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02408744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*